Chinese biotech firm InnoCare delays HK IPO step on virus fears

Chinese biotech firm InnoCare delays HK IPO step on virus fears

Liquid is poured from a beaker in a lab. Photographer: Michael Fein/Bloomberg

31 January, 2020

Printed by Unregistered user on Tue, 22 Jul 2025 08:25:13 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China's InnoCare is said to plan a Hong Kong IPO to raise about $250m

Venture Capital

Healthcare investment firm Vivo Capital leads $55m round in Beijing Innocare

Read more from Greater China

Venture Capital

Startup funding in Greater China grows 13% in Q2 on Ximalaya’s $2.4b deal

Cannot rely solely on valuation metrics for AI investments: Cathay Innovation